Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

25.3K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

335
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
335
Bias01:22

Bias

7.2K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
7.2K
Drug Regulation01:25

Drug Regulation

2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
Pharmacovigilance01:19

Pharmacovigilance

1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Segmental Spinal Dysgenesis.

Ochsner journal·2020
Same author

An Analysis of Informed Consent Form Readability of Oncology Research Protocols.

Journal of empirical research on human research ethics : JERHRE·2018
Same author

Do N-of-1 Trials Need IRB Review?

Journal of empirical research on human research ethics : JERHRE·2016
Same author

Physician Relationships with Industry.

Ochsner journal·2016
Same author

Bioethics in practice - a quarterly column about medical ethics: ethics of chart review research.

Ochsner journal·2013
Same author

From the Editor's Desk.

Ochsner journal·2011

Related Experiment Video

Updated: Dec 24, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K

Pitfalls and Safeguards in Industry-Funded Research.

Joseph L Breault1,2, Emily Knafl2

  • 1Former Chair, Institutional Review Board, and Senior Physician, Department of Family Medicine, Ochsner Clinic Foundation, New Orleans, LA.

Ochsner Journal
|April 15, 2020
PubMed
Summary

Physician-industry relationships require ethical oversight to maintain patient trust. Transparency and adherence to professional standards are crucial to prevent conflicts of interest and preserve the doctor-patient relationship.

Keywords:
Biasconflict of interestethicsresearch

More Related Videos

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

2.0K
A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

6.0K

Related Experiment Videos

Last Updated: Dec 24, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.6K
Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

2.0K
A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

6.0K

Area of Science:

  • Medical Ethics
  • Physician-Industry Relations

Background:

  • Physician relationships with industry must adhere to ethical principles.
  • Perceived conflicts of interest can erode trust in the patient-physician relationship.

Purpose of the Study:

  • Identify potential pitfalls in physician-industry relationships.
  • Outline safeguards to prevent ethical transgressions and damage to doctor-patient relationships.

Main Methods:

  • Analysis of ethical principles governing physician-industry interactions.
  • Review of safeguards to mitigate conflicts of interest.

Main Results:

  • Patient trust is undermined if physicians prioritize research over patient interests.
  • The Sunshine Act ensures transparency in industry payments to physicians.
  • Research subsidies must reflect fair market value; postmarketing trials for prescribing rates should be avoided.
  • Medical societies are vital in setting professional conduct standards.

Conclusions:

  • Ethical physician-industry actions require guidance from professional standards.
  • Adherence to medical society guidelines and institutional policies is essential.
  • Maintaining trust necessitates vigilance in managing physician-industry relationships.